It is my greatest pleasure to welcome you to the 9th HKIOS, which will take place in the Mira Hong Kong from 5th to 6th November 2022.
Ever since the establishment of the Hong Kong Precision Oncology Society, we have witnessed a number of important challenges in the field. In medical research, randomized clinical trials (RCTs) are the golden standard to estimate the causal inference between treatment interventions and outcomes. In the era of precision oncology, many common cancers can be subclassified into different small molecular subsets, and there may not be sufficient number of research subjects for running RCTs for various molecular types in a trial setting. Real world data (RWD) are the data relating to patient health status and/or the delivery of healthcare, routinely collected from a variety of sources regardless of the size of data. It is a mixture of digital transformation, statistics, data science, public health, reimbursement, pricing of products and regulatory science. In the upcoming symposium, our world renowned experts will highlight the various important recent advances of applying genomic information to clinical oncological care.
Gold Plus Sponsor